Literature DB >> 25112693

Factors affecting the natural decay of hepatitis B surface antigen in children with chronic hepatitis B virus infection during long-term follow-up.

Yu-Chun Chiu1, Shu-Fen Liao2, Jia-Feng Wu3, Chun-Yin Lin4, Wen-Chung Lee2, Huey-Ling Chen5, Yen-Hsuan Ni6, Hong-Yuan Hsu3, Mei-Hwei Chang7.   

Abstract

OBJECTIVE: To investigate the factors predicting spontaneous clearance of hepatitis B surface antigen (HBsAg) in a long-term, prospectively followed cohort from childhood into adult life. STUDY
DESIGN: Children with chronic hepatitis B virus (HBV) infection without treatment were followed longitudinally every 6 months. At each visit, liver profiles and HBV markers were assessed. Hepatitis B vaccination history and the maternal HBV markers also were studied.
RESULTS: A total of 349 children (205 male) were followed for 20.6 ± 4.4 years with initial ages of 8.4 ± 3.9 years; 42 (12.0%) cleared HBsAg spontaneously. The HBsAg titers decayed with age, with an average annual clearance rate of 0.58%. Children had a lower annual HBsAg decay rate if their mothers are HBsAg carriers (P < .001). Hepatitis B e antigen-seroconversion is a favorable predictor for spontaneous HBsAg clearance (P = .04). Those with HBsAg titer ≤1000 IU/mL at enrollment during childhood have a higher rate of HBsAg clearance (hazard ratio = 5.23; P < .001). Using HBsAg titer ≤1000 IU/mL to predict HBsAg clearance, the sensitivity is 38.1%, specificity is 90.6%, positive predictive value is 35.6%, and negative predictive value is 91.4%.
CONCLUSIONS: During long-term follow-up, spontaneous HBsAg clearance is most likely to occur in a patient born to a non-HBsAg-carrier mother, is a hepatitis B e antigen-seroconverter, and had an initial HBsAg level ≤1000 IU/mL.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25112693     DOI: 10.1016/j.jpeds.2014.06.059

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

2.  Children with Chronic Hepatitis B in the United States and Canada.

Authors:  Kathleen B Schwarz; Yona Keich Cloonan; Simon C Ling; Karen F Murray; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Lilia Ganova-Raeva; Philip Rosenthal
Journal:  J Pediatr       Date:  2015-09-10       Impact factor: 4.406

3.  Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada.

Authors:  Simon C Ling; Hsing-Hua S Lin; Karen F Murray; Philip Rosenthal; Douglas Mogul; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Kathleen B Schwarz
Journal:  J Pediatr       Date:  2021-05-20       Impact factor: 6.314

4.  High Prevalence of Hepatitis B Virus Infection in the Age Range of 20-39 Years Old Individuals in Lome.

Authors:  Malewe Kolou; Gnatoulma Katawa; Mounerou Salou; Komlan Selom Gozo-Akakpo; Sika Dossim; Alexander Kwarteng; Mireille Prince-David
Journal:  Open Virol J       Date:  2017-01-12

Review 5.  Host Genetic Determinants of Hepatitis B Virus Infection.

Authors:  Zhenhua Zhang; Changtai Wang; Zhongping Liu; Guizhou Zou; Jun Li; Mengji Lu
Journal:  Front Genet       Date:  2019-08-13       Impact factor: 4.599

6.  The impact of the timely birth dose vaccine on the global elimination of hepatitis B.

Authors:  Margaret J de Villiers; Shevanthi Nayagam; Timothy B Hallett
Journal:  Nat Commun       Date:  2021-10-28       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.